Matters to address prior to introducing new life support technology in Japan: three serious ethical concerns related to the use of left ventricular assist devices as destination therapy and suggested policies to deal with them.
Atsushi AsaiSakiko MasakiTaketoshi OkitaAya EnzoYasuhiro KadookaPublished in: BMC medical ethics (2018)
There is an urgent need for Japan to establish and enact a basic act for patient rights. The act should include: respect for a patient's right to self-determination; the right to refuse unwanted treatment; the right to prepare legally binding advance directives; the right to decline to prepare such directives; and access to nationally insured healthcare. It should enable those concerned with patient care involving DT to seek ethical advice from ethics committees. Furthermore, it should state that healthcare professionals involved in the discontinuation of life support in a proper manner are immune to any legal action and that they have the right to conscientiously object to LVAD deactivation.
Keyphrases
- healthcare
- left ventricular
- public health
- case report
- heart failure
- working memory
- decision making
- stem cells
- big data
- molecularly imprinted
- global health
- solid phase extraction
- coronary artery disease
- binding protein
- transcription factor
- artificial intelligence
- mesenchymal stem cells
- transcatheter aortic valve replacement
- left ventricular assist device
- smoking cessation